Acura Pharmaceuticals Change in Accounts Receivable 2010-2021 | ACUR
Acura Pharmaceuticals change in accounts receivable from 2010 to 2021. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
Acura Pharmaceuticals Annual Change in Accounts Receivable
(Millions of US $) |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$0 |
| 2018 |
$0 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2015 |
$0 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$N/A |
| 2011 |
$0 |
| 2010 |
$0 |
| 2009 |
$3 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.001B |
$0.000B |
|
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
|
